Kondro Acute Tablet is a combination pharmaceutical formulation containing Diacerein 50 mg and Glucosamine 1500 mg, designed to support joint health and alleviate symptoms associated with osteoarthritis. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and chondroprotective properties by inhibiting interleukin-1 beta (IL-1β), a key mediator in cartilage degradation and inflammation. Glucosamine, a naturally occurring amino sugar, serves as a vital substrate for the biosynthesis of glycosaminoglycans and proteoglycans, essential components of cartilage matrix, thereby promoting cartilage repair and maintenance. This synergistic combination aims to reduce joint pain, improve mobility, and slow the progression of degenerative joint diseases. Kondro Acute Tablet is indicated for patients suffering from osteoarthritis of the knee, hip, and other joints, providing symptomatic relief and enhancing joint function. The medication is generally well-tolerated; however, patients should be monitored for gastrointestinal disturbances, allergic reactions, or hypersensitivity. It is contraindicated in individuals with known hypersensitivity to either component, severe hepatic or renal impairment, and should be used cautiously in pregnant or lactating women. Regular medical supervision is recommended to assess therapeutic response and manage any adverse effects. Kondro Acute Tablet represents an effective option in the multimodal management of osteoarthritis, improving patient quality of life through targeted joint support.